Literature DB >> 22944093

An open randomized controlled trial of median sternotomy versus anterolateral left thoracotomy on morbidity and health care resource use in patients having off-pump coronary artery bypass surgery: the Sternotomy Versus Thoracotomy (STET) trial.

Chris A Rogers1, Katie Pike, Gianni D Angelini, Barnaby C Reeves, Mattia Glauber, Matteo Ferrarini, Gavin J Murphy.   

Abstract

OBJECTIVE: Our objective was to compare off-pump coronary artery bypass surgery carried out via a left anterolateral thoracotomy (ThoraCAB) or via a conventional median sternotomy (OPCAB).
BACKGROUND: Recent advances in minimally invasive cardiac surgery have extended the technique to allow complete surgical revascularization on the beating heart via thoracotomy.
METHODS: Patients undergoing nonemergency primary surgery were enrolled between February 2007 and September 2009 at 2 centers. The primary outcome was the time from surgery to fitness for hospital discharge as defined by objective criteria.
RESULTS: A total of 93 patients were randomized to off-pump coronary artery bypass surgery via a median sternotomy (OPCAB) and 91 to off-pump coronary artery bypass surgery via a left anterolateral thoracotomy (ThoraCAB). The surgery was longer for patients in the ThoraCAB group (median, 4.1 vs 3.3 hours) and there were fewer with more than 3 grafts (2% vs 17%). The median time from surgery to fitness for discharge was 6 days (interquartile range, 4-7) in the ThoraCAB group versus 5 days (interquartile range, 4-7) in the OPCAB group (P = .53). The intubation time was shorter, by on average 65 minutes, in the ThoraCAB group (P = .017), although the time in intensive care was similar (P = .91). Pain scores were similar (P = .97), but more analgesia was required in the ThoraCAB group (median duration, 38.8 vs 35.5 hours, P < .001; tramadol use, 66% vs 49%, P = .024). ThoraCAB was associated with significantly worse lung function at discharge (average difference, -0.25 L, P = .01) but quality of life scores at 3 and 12 months were similar (P = .52). The average total cost was 10% higher with ThoraCAB (P = .007).
CONCLUSIONS: ThoraCAB resulted in no overall clinical benefit relative to OPCAB.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  1; 23; 23.1; 28; CABG; CI; CPB; FEV(1); FVC; IL; MICS; MIDCAB; OPCAB; RCT; SIRS; TR; ThoraCAB; cardiopulmonary bypass; confidence interval; coronary artery bypass graft; forced expiratory volume after 1 second; forced vital capacity; interleukin; minimally invasive cardiac surgery; minimally invasive direct coronary artery bypass; off-pump coronary artery bypass surgery via a left anterolateral thoracotomy; off-pump coronary artery bypass surgery via a median sternotomy; randomized controlled trial; systemic inflammatory response syndrome; time ratio

Mesh:

Substances:

Year:  2012        PMID: 22944093     DOI: 10.1016/j.jtcvs.2012.04.020

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Factors causing prolonged mechanical ventilation and peri-operative morbidity after robot-assisted coronary artery bypass graft surgery.

Authors:  Huan Hsu; Hui-Chin Lai; Tsun-Jui Liu
Journal:  Heart Vessels       Date:  2018-07-13       Impact factor: 2.037

2.  Robot-assisted coronary artery bypass grafting improves short-term outcomes compared with minimally invasive direct coronary artery bypass grafting.

Authors:  Wenhui Gong; Junfeng Cai; Zhe Wang; Anqing Chen; Xiaofeng Ye; Haiqing Li; Qiang Zhao
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

3.  Multivessel coronary artery revascularization through left mini-anterior thoracotomy.

Authors:  Mugisha Kyaruzi; Yasemen Durak Erdinç; Barış Çaynak
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

Review 4.  Meta-analysis of interleukin 6, 8, and 10 between off-pump and on-pump coronary artery bypass groups.

Authors:  Fanbo Meng; Jianghong Ma; Wei Wang; Baisong Lin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

Review 5.  Does a minimally invasive approach result in better pulmonary function postoperatively when compared with median sternotomy for coronary artery bypass graft?

Authors:  Andrew Dooley; George Asimakopoulos
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-26

6.  Review of Contemporary Techniques for Minimally Invasive Coronary Revascularization.

Authors:  Ali Fatehi Hassanabad; Jimmy Kang; Andrew Maitland; Corey Adams; William D T Kent
Journal:  Innovations (Phila)       Date:  2021-06-03

7.  Minimally invasive compared to conventional approach for coronary artery bypass grafting improves outcome.

Authors:  Jitumoni Baishya; Antony George; Jayaprakash Krishnamoorthy; Geetha Muniraju; Murali Chakravarthy
Journal:  Ann Card Anaesth       Date:  2017 Jan-Mar

8.  Perioperative outcomes in minimally invasive direct coronary artery bypass versus off-pump coronary artery bypass with sternotomy.

Authors:  Ali İhsan Tekin; Ümit Arslan
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-05-12       Impact factor: 1.195

9.  Minimally invasive coronary artery bypass as a safe method of surgical revascularization. The step towards hybrid procedures.

Authors:  Jacek Piątek; Anna Kędziora; Janusz Konstanty-Kalandyk; Grzegorz Kiełbasa; Marta Olszewska; Krzysztof Wróbel; Bryan HyoChan Song; Tomasz Darocha; Marcin Wróżek; Bogusław Kapelak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-11-29       Impact factor: 1.426

10.  Trial protocol for a randomised controlled trial of red cell washing for the attenuation of transfusion-associated organ injury in cardiac surgery: the REDWASH trial.

Authors:  G J Murphy; V Verheyden; M Wozniak; N Sullo; W Dott; S Bhudia; N Bittar; T Morris; A Ring; A Tebbatt; T Kumar
Journal:  Open Heart       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.